Your session is about to expire
← Back to Search
Virtual Mindfulness for Autism
N/A
Waitlist Available
Led By Yona Lunsky, PhD
Research Sponsored by Centre for Addiction and Mental Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 week (group b)
Awards & highlights
Study Summary
This trial tests the effects of a virtual group mindfulness intervention for autistic adults on their mental health and well-being. Results will be compared to those who don't get the intervention.
Who is the study for?
This trial is for autistic adults who can join online groups, have internet and a computer or tablet, are at least 18 years old, and can understand and communicate in English. It's not for those with intellectual disabilities or without the tech needed to participate.Check my eligibility
What is being tested?
The study tests if virtual group mindfulness helps improve mental health and well-being in autistic adults compared to those on a waitlist. Participants' mental health will be assessed after the intervention and again at 15 weeks.See study design
What are the potential side effects?
Since this is a non-medical intervention focusing on mindfulness through virtual sessions, there may not be direct physical side effects; however, participants might experience emotional discomfort or fatigue from engaging in the exercises.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ end of the study
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of the study
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Psychological distress: measured using the Depression and Anxiety Stress Scale (DASS-21)
Secondary outcome measures
Autistic Community connectedness (ACC) - measured using Autistic Community Connectedness Measure (ACC)
Autistic Participant Interoception measured using, Interoception Sensory Questionnaire (ISQ-8)
Autistic Participant Satisfaction-measured using Intervention Satisfaction Scale (ISS)
+4 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Mindfulness Intervention (Group-A)Experimental Treatment1 Intervention
Total length of study for participants in Group-A:15 Week
Six weekly sessions (each 60 minutes in length) of group based virtual mindfulness instruction, co-led by a mindfulness teacher and two autistic adults, following a workbook designed for autistic adults. In between sessions, participants are encouraged to complete homework and keep a record of when they practice formal and informal mindfulness practices. In addition, participants are provided with a link to autism informed mental health resources (https://www.yorku.ca/health/lab/ddmh/am-help/)
Group II: Waitlist Control (Group-B)Active Control1 Intervention
Total length of study for participants in Group-B: 30 Week
A waitlist control group is an ethical alternative to no-treatment control groups when studying psychological and behavioral interventions. This group will have access to intervention at the end of the study as well. All waitlist participants are provided with a link to autism informed mental health resources (https://www.yorku.ca/health/lab/ddmh/am-help/)
Find a Location
Who is running the clinical trial?
Centre for Addiction and Mental HealthLead Sponsor
356 Previous Clinical Trials
81,377 Total Patients Enrolled
3 Trials studying Autism Spectrum Disorder
170 Patients Enrolled for Autism Spectrum Disorder
Yona Lunsky, PhDPrincipal InvestigatorCAMH
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can join and participate in online groups by myself.I cannot understand, speak, or write in English.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Waitlist Control (Group-B)
- Group 2: Mindfulness Intervention (Group-A)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants is the trial team seeking to include?
"Indeed, clinicaltrials.gov affirms that the trial was published on November 17th 2022 and is actively recruiting patients. 80 individuals will be admitted at a single site for participation in this study."
Answered by AI
Are there vacancies available for participants of this research?
"Affirmative. According to clinicaltrials.gov, this medical experiment is actively searching for participants and was initially published on November 17th 2022; the same date marks its most recent update. The total number of patients needed is 80 from a single centre."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger